WMT

111.9

-0.51%↓

COST

865.6

-0.25%↓

TGT

97.45

-0.62%↓

62.68

+0.05%↑

DG.US

135.78

-1.2%↓

WMT

111.9

-0.51%↓

COST

865.6

-0.25%↓

TGT

97.45

-0.62%↓

62.68

+0.05%↑

DG.US

135.78

-1.2%↓

WMT

111.9

-0.51%↓

COST

865.6

-0.25%↓

TGT

97.45

-0.62%↓

62.68

+0.05%↑

DG.US

135.78

-1.2%↓

WMT

111.9

-0.51%↓

COST

865.6

-0.25%↓

TGT

97.45

-0.62%↓

62.68

+0.05%↑

DG.US

135.78

-1.2%↓

WMT

111.9

-0.51%↓

COST

865.6

-0.25%↓

TGT

97.45

-0.62%↓

62.68

+0.05%↑

DG.US

135.78

-1.2%↓

Home・Akcijų sąrašas・USANA Health Sciences Inc

USANA Health Sciences Inc

Uždarymo kaina

19.87 0.76

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

19.31

Max

19.94

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-17M -6.7M
Pardavimai	-22M 214M
P/E Sektoriaus vid.	21.922 28.154
Pelnas, tenkantis vienai akcijai	-0.15
Pelno marža	-3.118
Darbuotojai	1,700
EBITDA	-17M 11M

Rekomendacijos
By TipRanks
Rekomendacijos	Neutralu
12 mėnesių prognozė	+97.67% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-21M 361M
Ankstesnė atidarymo kaina	19.11
Ankstesnė uždarymo kaina	19.87

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

28.405 / 29.84 Palaikymas ir pasipriešinimas

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-30 23:49; UTC

Įsigijimai, susijungimai, perėmimai

WiseTech to Sell Expedient to Appease Competition Regulator

2025-12-30 17:12; UTC

Pagrindinės rinkos jėgos

CapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera

2025-12-30 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-30 21:16; UTC

Įsigijimai, susijungimai, perėmimai

Penguin Solutions: Smart Modular to Sell Zilia Stake for $46M

2025-12-30 21:08; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Take Another Wild Ride -- Market Talk

2025-12-30 20:41; UTC

Rinkos pokalbiai

Oil Futures Settle Lower in Sluggish Trade -- Market Talk

2025-12-30 20:37; UTC

Uždarbis

The 5 Best Names to Play AI in 2026, According to Wall Street's Loudest Tech Bull -- Barrons.com

2025-12-30 19:29; UTC

Rinkos pokalbiai

Corn Extends Pullback in Light Trade -- Market Talk

2025-12-30 18:29; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises By Three to 412 -- Market Talk

2025-12-30 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-30 16:20; UTC

Uždarbis

Boeing Stock Is on a Roll. Why It Could Gain 25% in the Next Year. -- Barrons.com

2025-12-30 16:18; UTC

Įsigijimai, susijungimai, perėmimai

Meta Buys AI Startup Manus, Adding Millions of Paying Users -- 2nd Update

2025-12-30 16:10; UTC

Rinkos pokalbiai

Eurozone Government Bond Yields Rise, Euro Falls Ahead of Fed Minutes -- Market Talk

2025-12-30 15:24; UTC

Rinkos pokalbiai

Australian Dollar Could Rise Versus Sterling -- Market Talk

2025-12-30 15:10; UTC

Įsigijimai, susijungimai, perėmimai

Meta Stock Rises After Buying Manus. What the China-Founded AI Start-Up Brings. -- Barrons.com

2025-12-30 14:24; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: The Three Publications Are Challenges, Sciences & Avenir, and La Recherche

2025-12-30 14:22; UTC

Įsigijimai, susijungimai, perėmimai

LVMH : Szafran Will Serve as Publishing Director For all Three Publications

2025-12-30 14:20; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: As Part of the Deal, Maurice Szafran Has Been Named President of Les Editions Croque Futur

2025-12-30 14:17; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: The Deal Also Reflects LVMH's Commitment to Support High-Quality Information and Scientific Culture

2025-12-30 14:16; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: The Deal Aims to Accelerate the Development and Distribution of the Publications Mainly in Digital Format

2025-12-30 14:14; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: The Move Includes Three Publications Into UFIPAR Investment Company

2025-12-30 14:12; UTC

Įsigijimai, susijungimai, perėmimai

LVMH: Les Editions Croque Futur Is a French Publishing House

2025-12-30 14:10; UTC

Įsigijimai, susijungimai, perėmimai

LVMH Acquires Les Editions Croque Futur

2025-12-30 13:49; UTC

Įsigijimai, susijungimai, perėmimai

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

2025-12-30 13:36; UTC

Rinkos pokalbiai

U.S. Natural Gas Continues Weather-Driven Rally -- Market Talk

2025-12-30 13:30; UTC

Rinkos pokalbiai

Crude Futures Gain in Light Holiday Trade -- Market Talk

2025-12-30 12:55; UTC

Rinkos pokalbiai

Triple Flag Precious Metals Offers Opportunity While Mitigating Risk -- Market Talk

2025-12-30 11:55; UTC

Rinkos pokalbiai

Uždarbis

Investors Await Tesco's Profit Outlook Following U.K. Budget Reforms -- Market Talk

2025-12-30 11:47; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Meta's Manus Deal Is a Taster of AI Trends for 2026. Watch This Risk. -- Barrons.com

2025-12-30 11:35; UTC

Įsigijimai, susijungimai, perėmimai

Meta Buys Manus. What the China-Founded AI Start-Up Brings for Zuckerberg. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Kainos tikslas

By TipRanks

97.67% į viršų

12 mėnesių prognozė

Vidutinis 39 USD 97.67%

Aukščiausias 39 USD

Žemiausias 39 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines USANA Health Sciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių USANA Health Sciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.